CN2936292Y - Disposable urethral medicine package administration device - Google Patents
Disposable urethral medicine package administration device Download PDFInfo
- Publication number
- CN2936292Y CN2936292Y CN 200620026919 CN200620026919U CN2936292Y CN 2936292 Y CN2936292 Y CN 2936292Y CN 200620026919 CN200620026919 CN 200620026919 CN 200620026919 U CN200620026919 U CN 200620026919U CN 2936292 Y CN2936292 Y CN 2936292Y
- Authority
- CN
- China
- Prior art keywords
- drug
- release
- sustained
- intrauterine
- controlled release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The utility model provides an intrauterine drug delivery device for the controlled/sustained release drug, comprising a body which is a hollow body with the controlled/sustained release drug inside. The body can be directly made into various shapes to put within the uterine cavity or to attach to a stand suitable for placement within the uterine cavity so as to achieve the purpose of treating gynecological diseases or antifertility. The direct action on the target organ can decrease the drug dose and avoid high drug concentration in the blood in the whole body, thus decreasing drug side effects. The effect can also be used for prolonging action of treatment or antifertility so as to greatly facilitate the users. In the event of severe drug reaction, the body can be conveniently taken out of the body of the patients so that the release of the drugs can be stopped in time, thus the use is safe.
Description
One, technical field
This utility model relates to the intrauterine doser, relates in particular to a kind of intrauterine doser with fixing long-acting sustained-release and controlled release drug form.
Two, background technology
Present treatment various gynecological diseases comprises the method for married woman's antifertility, and portion is to use the medicine mode, and that the route of administration of these medicines comprises is oral, injection, subdermal implantation or Transdermal absorption etc.
These medicines make systemic blood concentration reach treatment level after being absorbed by the body by existing administering mode, thereby affact target organ (uterus, ovary etc.), play the effect of treatment or antifertility.Since the whole body blood drug level that existing administering mode is had relatively high expectations, so every day very high drug dose to be arranged, and the side effects of pharmaceutical drugs performance is obviously.In addition, because present administering mode is not long lasting, so the patient must takes medicine every day, and is very inconvenient, also influences because miss probably and treats or the antifertility effect.
Along with the appearance of long-acting slow-release controlled release form medicine, the gynecopathy therapeutic mode of the local long-acting administration of target organ becomes possibility, but how long-acting slow-release controlled release form medicine is fixed on target organ, never good solution.
Three, utility model content
Main purpose of the present utility model is the difficulty that exists in the local long-acting drug treatment scheme of target organ, a kind of intrauterine doser with fixing long-acting sustained-release and controlled release drug form is provided, it comprises body, this body can directly be set as the different shape that can be placed in the cavity of uterus, also can be attached on the existing support that is fit to be placed in the cavity of uterus, place in the intrauterine doser body and have the sustained-release and controlled release drug form, play the effect of treatment gynaecopathia or antifertility, and can reduce drug dose by directly acting on target organ, avoid the high concentration of whole body blood medicine, thereby reduction drug side effect, simultaneously, can also play the purpose of long-acting treatment or antifertility, make things convenient for user greatly; In addition,, can easily body of the present utility model and long-acting slow-release controlled release form medicine be taken out in patient's body immediately, in time stop the release of medicine in case serious drug reaction occurs, safe in utilization.
The purpose of this utility model is realized by following technical scheme.
The utlity model has the intrauterine doser of sustained-release and controlled release drug form, comprise body; It is characterized in that described body is the inner ducted body that is placed with the sustained-release and controlled release drug form, this ducted body wall is a reticulate body.
Aforesaid intrauterine doser with sustained-release and controlled release drug form, wherein body is made by the material with suppleness, and its internal diameter is 1mm to 5mm, and wall thickness is 0.1mm to 2mm.
Aforesaid intrauterine doser with sustained-release and controlled release drug form, wherein body directly is set as the shape that can be placed in the cavity of uterus.
Aforesaid intrauterine doser with sustained-release and controlled release drug form, wherein body is attached on the support that can be placed in the cavity of uterus, and attachment area is more than one.
The beneficial effect that the utlity model has the intrauterine doser of sustained-release and controlled release drug form is, pass through topical, directly act on target organ and reduce drug dose, avoid the high concentration of whole body blood medicine, thereby reduction drug side effect, simultaneously, can also play the purpose of long-acting treatment or antifertility, make things convenient for user greatly.In addition,, can easily body of the present utility model and long-acting slow-release controlled release form medicine be taken out in patient's body immediately, in time stop the release of medicine in case serious drug reaction occurs, safe in utilization.
Four, description of drawings
Fig. 1 is this utility model overall structure sketch map.
Fig. 2 is a cross section structure sketch map shown in Figure 1.
Fig. 3 directly is set as annular intrauterine doser sketch map for this utility model body.
Fig. 4 is that this utility model body is attached to the existing various structural representations on the intrauterine support that are fit to be placed on.
Major label description in figure: 1 has intrauterine doser, 11 bodies, 12 medicines, the 2 existing in utero stake bodies of sustained-release and controlled release drug form.
Five, the specific embodiment
Consult Fig. 1, shown in Figure 2, the utlity model has the intrauterine doser 1 of sustained-release and controlled release drug form, comprise body 11, this body 11 is the inner ducted body that sustained-release and controlled release drug form 12 is set, the wall of body 11 is a reticulate body, and body 11 can be that the material with suppleness is made, and this material with suppleness can be polypropylene, polyethylene or polyformaldehyde material, its internal diameter is 1mm to 5mm, and wall thickness is 0.1mm to 2mm.
Consult shown in Figure 3, the utlity model has the intrauterine doser 1 of sustained-release and controlled release drug form, its body 11 can directly be set as the different shape that can be placed in the cavity of uterus, present embodiment directly is set as annular solid with body 11 and describes, sustained-release and controlled release drug form 12 is equipped with in these ring body 11 inside, sustained-release and controlled release drug form 12 discharges towards intrauterine by the net walls of body 11, plays the effect of treatment gynaecopathia or antifertility.
Consult shown in Figure 4, the utlity model has intrauterine doser 1 another embodiment of long-acting slow-release controlled release form medicine, its body 11 is attached on existing a kind of in utero stake body 2, attachment area can be for more than one, sustained-release and controlled release drug form 12 is equipped with in body 11 inside, sustained-release and controlled release drug form 12 discharges towards intrauterine by the net walls of body 11, plays the effect of treatment gynaecopathia or antifertility.Existing in utero support 2 has been proved to be and has been fit to be placed in the cavity of uterus, body 11 of the present utility model is attached on the existing in utero support, just can play the effect that is positioned over slow releasing pharmaceutical in the cavity of uterus and makes it to continue to discharge, needn't design new support again, its advantage is the placement device and the laying method of the very familiar existing support of doctor, easy to operate, and can reduce cost.The adherence method of facies posterior hepatis 21 comprises modes such as winding, stickup, engaging or single injection-molded, and present embodiment adopts canoe to make body 11 attached to the T font in utero on the stake body 2, and facies posterior hepatis 21 is three.
When the utlity model has intrauterine doser 1 enforcement of sustained-release and controlled release drug form, the sustained-release and controlled release drug form and the various forms of sustained-release and controlled release drug form of multiple different drug effects can be placed in its body 11 inside, to reach the effect of treatment gynaecopathia or antifertility.When use the utlity model has the intrauterine doser 1 of sustained-release and controlled release drug form, can utilize the existing in utero general special placement device of stake body, the various bodies 11 that are placed in the cavity of uterus are placed in the cavity of uterus, and laying method is a prior art, so repeat no more.
This utility model body 11 is the inner ducted body that sustained-release and controlled release drug form 12 is set, the wall of body 11 is a reticulate body, has certain suppleness, therefore, can directly be set as the shape that can be placed in the cavity of uterus, perhaps attached on the existing various in utero stake bodies 2, the sustained-release and controlled release drug form and the various forms of sustained-release and controlled release drug form of multiple different drug effects is equipped with in body 11 inside, plays the effect of treatment or antifertility; After it is placed in the cavity of uterus, the inner sustained-release and controlled release drug form of placing of ducted body (generally more than 2 years) for a long time remains in the cavity of uterus, slowly the medicine that discharges sees through netted wall and acts on the target organ, can continue quantitatively to discharge medicine 24 hours every days, reach the effect of treatment gynaecopathia or antifertility, adopt the advantage of this mode administration to be, directly discharge medicine at target organ, can avoid too high whole body blood drug level, reduce the side effect of using other administering modes greatly, reduce drug dose, avoid regular, the trouble of timing frequent drug administration, when in case serious adverse reaction occurring, can be immediately in the cavity of uterus whole the taking-up, can not produce more major injury. safe and reliable.
The above, it only is preferred embodiment of the present utility model, be not that this utility model is done any pro forma restriction, every foundation technical spirit of the present utility model all still belongs in the scope of technical solutions of the utility model any simple modification, equivalent variations and modification that above embodiment did.
Claims (4)
1, a kind of intrauterine doser with sustained-release and controlled release drug form comprises body; It is characterized in that described body is the inner ducted body that is placed with the sustained-release and controlled release drug form, this ducted body wall is a reticulate body.
2, the intrauterine doser with sustained-release and controlled release drug form according to claim 1 is characterized in that described body is made by the material with suppleness, and its internal diameter is 1mm to 5mm, and wall thickness is 0.1mm to 2mm.
3, the intrauterine doser with sustained-release and controlled release drug form according to claim 1 is characterized in that, described body directly is set as the shape that can be placed in the cavity of uterus.
4, the intrauterine doser with sustained-release and controlled release drug form according to claim 1 is characterized in that, described body is attached on the support that can be placed in the cavity of uterus, and attachment area is more than one.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200620026919 CN2936292Y (en) | 2006-08-03 | 2006-08-03 | Disposable urethral medicine package administration device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200620026919 CN2936292Y (en) | 2006-08-03 | 2006-08-03 | Disposable urethral medicine package administration device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN2936292Y true CN2936292Y (en) | 2007-08-22 |
Family
ID=38360311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200620026919 Expired - Fee Related CN2936292Y (en) | 2006-08-03 | 2006-08-03 | Disposable urethral medicine package administration device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN2936292Y (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105013072A (en) * | 2015-07-24 | 2015-11-04 | 严聪颖 | Medicine-taking slow release device for uterus, and implantation method |
-
2006
- 2006-08-03 CN CN 200620026919 patent/CN2936292Y/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105013072A (en) * | 2015-07-24 | 2015-11-04 | 严聪颖 | Medicine-taking slow release device for uterus, and implantation method |
| CN105013072B (en) * | 2015-07-24 | 2018-08-31 | 严聪颖 | Band medicine delayed release device for uterus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9555168B2 (en) | System for delivery of medication in treatment of disorders of the pelvis | |
| JP2002515069A (en) | Apparatus and method for treatment of dysmenorrhea | |
| ES2265181T3 (en) | ADMINISTRATION SYSTEM OF PHARMACOS. | |
| EA200501420A1 (en) | DELIVERY DEVICE FOR DRUG AND CELL THERAPY | |
| RU2015109296A (en) | MEDICINAL DELIVERY SYSTEMS AND METHODS FOR TREATMENT OF BLADDER CANCER, INCLUDING THE USE OF OXALIPLATIN | |
| CN206566005U (en) | A kind of multi-functional uterine cavity resilient bladder support | |
| CN2936292Y (en) | Disposable urethral medicine package administration device | |
| US20130269706A1 (en) | Barrel-shaped vaginal ring | |
| CN201618299U (en) | Intrauterine medicine slow-release device | |
| CN102974025B (en) | A kind of one-off cervix dilator with medicine film | |
| CN2647347Y (en) | Carrier suppository for gynecology | |
| CN215080478U (en) | Quantitative medicine-carrying rib fixing plate | |
| RU2005128284A (en) | EXTENDED MODES OF PERCUTANEOUS CONTRACEPTION | |
| CN208877686U (en) | A kind of novel gynecology medicine delivery device | |
| CN215082515U (en) | Arrow type female animal genital tract slow-release medicine dosage form and putting fixing device | |
| CN201030142Y (en) | Carrier suppository for gynecology | |
| CN201012136Y (en) | Vagina targeting drug administration device | |
| CN2416900Y (en) | Local applying medicine slow-released device for treating gynecopathy | |
| CN211357379U (en) | Medicine feeder for treating uterine inflammation | |
| CN210472777U (en) | Vagina drug administration injector | |
| CN2587436Y (en) | Prefilled disposable medicator | |
| CN220989408U (en) | Microneedle patch | |
| CN201564960U (en) | Disposable vagina dosing device | |
| CN200998472Y (en) | Postoperative regional anesthesia analgesia bag | |
| CN2210680Y (en) | Device for treating women's diseases of uterine neck and vagina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070822 |